RH’s Tariff Warning, Media Mergers, The Next Frontier for Weight Loss Drugs 9/12/25
RH just the latest company to warn about the impact of tariffs on its earnings. Its CEO adding this is probably the worst housing market in 50 years. Then what could a potential bid from Paramount Skydance for Warner Brothers Discovery mean for the media landscape? And Novo Nordisk prepares for the launch of an oral version of its blockbuster weight loss drug. A look at the competition with Eli Lilly.
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
RH just the latest company to warn about the impact of tariffs on its earnings. Its CEO adding this is probably the worst housing market in 50 years. Then what could a potential bid from Paramount Skydance for Warner Brothers Discovery mean for the media landscape? And Novo Nordisk prepares for the launch of an oral version of its blockbuster weight loss drug. A look at the competition with Eli Lilly.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.